Drug recall · December 25, 2019
Gabapentin Capsules recall
Why: Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99
- Lots / codes
Lot #: 19819029A3, Exp. 08/2021
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide within the United States
- Initiated
- November 19, 2019 · Voluntary: Firm initiated
- Classified
- January 8, 2020
- Reported
- December 25, 2019
- Ended
- April 4, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.